<!DOCTYPE html>
<html>
  <head>
    <title>TKSL Labs</title>
    <link rel="stylesheet" href="stylesheet.css" />
  </head>

  <body>
    <ul class="navbar">
      <li>
        <p>TKSL Labs</p>
      </li>
      <li><a href="/index.html">Home</a></li>
      <li><a href="/about.html">About</a></li>
      <li><a class="active" href="/tech.html">Technology</a></li>
      <li><a href="/products.html">Products</a></li>
       <li><a href="/science.html">Research</a></li>
      <li><a href="/news.html">News</a></li>
      <li><a href="/contact.html">Contact</a></li>
    </ul>
    <div class="header">
      <h1>Our Technology</h1>
      <div class="tech">
      <p>
        Our soon to be patented molecular technology (U.S. Patent Application No. 17/599,008; U.S. Patent Application No. 62/835,746; Intl. Patent Application No. PCT/US20/28064), allows for the prediction of
        the presence of genes that determine antibiotic resistance in certain
        pathogenic organisms that cause infecious diseases.
      </p>
      <h3>How do antibiotics work?</h3>
      <p>
        Antibiotics work by binding certain proteins or enzymes essential for
        cellular function of a disease-causing organism.
      </p>
       <h3>When does antibiotic resistance occur?</h3>
      <p>
        Antibiotic resistance occurs when those organims undergo genetic changes
        that alter the shape of those proteins where antibiotics bind, rendering
        the antibiotic useless and the organism resistant.
      </p>
        <h3>How does our technology work?</h3>
      <p>
        Our technology identifies the genetic sequence of the antibiotic target,
        determining if the genetic sequence of the organism is normal or changed.
      </p>
      <h3>Gonorrhea treatment success varies by genetic mutations <a href="https://pubmed.ncbi.nlm.nih.gov/31230613/" target='_blank' >(Sexual Health 2019)</a></h3>
      <img src="images/nihms-1045249-f0001.jpeg"/>
    </div>
  </body>
</html>
